Group: Scientific Advisory Board

V. Reid Sutton

Aceragen’s scientific advisor, Reid has committed himself to advancing scientific knowledge and patient care by applying his clinical skills to research questions. He has employed his knowledge and expertise in the diagnosis of genetic syndromes, dysmorphology, genetic mechanisms of disease, inborn errors of metabolism and skeletal dysplasias. In his role as the Medical Director of

Edward Schuchman

Edward serves on the Aceragen scientific advisory board for his breakthrough enzyme and Farber disease research. His team was the first to isolate genes encoding lysosomal enzymes linked to Types A and B Niemann-Pick, Mucopolysaccharidosis Type VI, and Farber disease. Those studies led to the first genetic screening program and clinical trials of enzyme replacement